Recent Finacing
Recent Raise
Morphogen-IX is a Cambridge biotech developing a pulmonary arterial hypertension therapy that targets a genetically implicated pathway, based on 15 years of Nick Morrell's Cambridge research and licensed IP.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors